All articles by Anthony King – Page 15
-
BusinessAbbot boosts heart devices with St Jude buyout
Medical devices consolidation continues with $25bn deal, but Abbott expresses concerns over proposed Alere merger
-
ResearchEarthly xenon’s asteroid origins reveal planet’s genesis
Discovery that atmospheric xenon is unrelated to that in the mantle hints at two separate extra-terrestrial ‘deliveries’ of the element
-
-
BusinessUS treasury rules scupper Pfizer–Allergan merger
Government aims to crack down on corporate tax avoidance through ‘inversion’ deals
-
News
Irish institute in hot water with university ranking agency
Quacquarelli Symonds unhappy with emails sent to academics asking them to take part in survey
-
NewsAntibiotic alternatives need to be recruited in fight against resistance
Vaccines, probiotics and other substitutes could help battle antimicrobial resistance as antibiotic effectiveness fades
-
BusinessOil slump reverberates in chemicals
Collapse in crude prices has complex and mixed effects on markets for derivative chemicals
-
FeatureA volatile question
VOCs are more than just a man-made problem. Anthony King looks through the wood to the trees
-
NewsPressure on controversial nanoparticle paper builds
Expression of concern and reprimand for chemists may seal fate of work on palladium particles
-
BusinessShire bets big on rare diseases
$32bn Baxalta buyout will deepen Shire’s commitment to developing specialist drugs for small patient populations
-
BusinessDow and DuPont mega-merger heralds break-up of giants
New firm will split itself in speciality, agrichemical and materials businesses with R&D taking a hit from cost savings
-
NewsAll boats to be lifted by Irish science strategy
Ambitious plan to double research spending relies on tapping the private sector to provide two-thirds of the money
-
NewsReview calls for tighter controls on antibiotic use in farming
Legally binding targets are needed to tackle resistance worldwide, latest report says
-
-
BusinessPfizer and Allergan agree mega-merger
$160 billion deal allows Pfizer to escape US tax system by re-homing in Ireland
-
NewsPoor management of antibiotics squandering life-saving drugs
Internet and over-the-counter sales along with counterfeit drugs are driving a worldwide rise in antimicrobial resistance
-
NewsEurope picks its panel of seven scientific advisers
The commission’s new advisory support team will be backed up by more money and resources than the chief scientific adviser post it replaces
-
NewsPoor diagnostics hinder battle against antibiotic resistance
Healthcare workers’ tools to diagnose infections remain stuck in the past
-
ResearchWildflowers serve as reservoir for controversial pesticides
Crop pollen has levels of neonicotinoid insecticides 10 times lower than native species
-
NewsChemistry at heart of VW emissions cheating
Car firm dodged nitrogen oxide pollution limits using software that detected testing